Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety and efficacy of different dosages and
administration schedules of an investigational agent administered over 3 days when added to
standard therapy used in the prevention of chemotherapy-induced nausea and vomiting in cancer
patients. Subjects will be asked to complete daily diaries while on study medication. In
addition subjects will be required to return to the investigational site several times during
the course of the study for follow up safety assessments which may include blood samples for
hematology and chemistry evaluations as well as physical exams. A final assessment will be
preformed on study Day 20-30 at which time the subject will complete the study.